Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > 4-(3-Chloropropyl)morpholine

4-(3-Chloropropyl)morpholine

4-(3-Chloropropyl)morpholine structure

4-(3-Chloropropyl)morpholine 

structure
  • CAS No:

    7357-67-7

  • Formula:

    C7H14ClNO

  • Chemical Name:

    4-(3-Chloropropyl)morpholine

  • Synonyms:

    Morpholine,4-(3-chloropropyl)-;4-(3-Chloropropyl)morpholine;3-Morpholinopropyl chloride;N-(3-Chloropropyl)morpholine;1-Chloro-3-morpholinopropane;NSC 28831;NSC 38889;3-Chloro-1-(morpholin-4-yl)propane;3-(Morpholin-4-yl)propyl chloride

  • Categories:

    Pharmaceutical Intermediates  >  Antineoplastics

Description

Pale Yellow Oil

4-(3-Chloropropyl)morpholine Basic Attributes

163.65

163.65

461-510-0

38889|28831

DTXSID70223769

2934999090

Characteristics

12.5

0.8

Light Yellow to Colourless Liquid

1.0409 g/cm3 @ Temp: 20 °C

NA

110-115 °C @ Press: 25 Torr

91.2±23.2 °C

1.463

-20ºC Freezer, Under Inert Atmosphere

Safety Information

R36/37/38

S26-S36/37/39

P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, P501

H302

|Danger|H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral]|P201, P202, P260, P264, P270, P280, P281, P301+P312, P302+P352, P305+P351+P338, P308+P313, P310, P314, P321, P330, P332+P313, P337+P313, P362, P405, and P501|Aggregated GHS information provided by 2 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.|Warning|H302+H312+H332 (16.67%): Harmful if swallowed, in contact with skin or if inhaled [Warning Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation]|P261, P264, P270, P271, P272, P280, P301+P312, P302+P352, P304+P312, P304+P340, P305+P351+P338, P312, P321, P322, P330, P332+P313, P333+P313, P337+P313, P362, P363, P403+P233, P405, and P501|Aggregated GHS information provided by 6 companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

4-(3-Chloropropyl)morpholine Use and Manufacturing

Methods of Manufacturing

To a solution of 1-bromo-3-chloropropane (10.0 g, 63.5 mmol) in toluene (100 mL) was added morpholine (11.0 mL, 127 mmol). a) A mixture of morpholine (261 ml, 3.00 mol) and 1-bromo-3-chloropropane (148 ml, 1.50 mol) in toluene (900 ml) was stirred for 18 hours at ambient temperature. Additional 1-bromo-3-chloropropane (25 ml, 0.25 mol) was added, the reaction was stirred for a further 1 hour and then filtered to remove the precipitated solid before the filtrate was concentrated in vacuo. Distillation of the crude oil yieldedb) N-(3-chloropropyl)-morpholine (119.3 g, 49 percent yield) as the fraction boiling at 70 - 80 °C / 2.6 mmHg :1H-NMR (DMSO d6): 3.65 (t, 2H), 3.55 (m, 4H), 2.40 (t, 2H), 2.39 (m, 4H), 1.85 (m, 2H) : MS (+ve ESI) : 164 (M+H)+.a) A mixture of morpholine (261 ml, 3.00 mol) and 1-bromo-3-chloropropane (148 ml, 1.50 mol) in toluene (900 ml) was stirred for 18 hours at ambient temperature. Additional 1-bromo-3-chloropropane (25 ml, 0.25 mol) was added, the reaction was stirred for a further 1 hour and then filtered to remove the precipitated solid before the filtrate was concentrated in vacuo. Distillation of the crude oil yielded N-(3-chloropropyl)-morpholine (119.3 g, 49percent yield) as the fraction boiling at 70-80° C./2.6 mmHg:A mixture of morpholine (261 ml, 3.00 mol) and 1-bromo-3-chloropropane (148 ml, 1.50 mol) in toluene (900 ml) was stirred for 18 hours at ambient temperature. Additional 1-bromo-3 -chloropropane (25 ml, 0.25 mol) was added, the reaction was stirred for a further 1 hour and then filtered to remove the precipitated solid before the filtrate was concentrated in vacuo. Distillation of the crude oil yielded N-(3-chloropropyl)-morpholine (119.3 g, 49 percent yield) as the fraction boiling at 70-80 °C / 2.6 mmHg : A solution of [L-CHLORO-3-BROMOPROPANE] in dry tetrahydrofuran (2 mL) was added to a cold suspension of morpholine (200 mg, 2.29 mmol) and sodium carbonate (0.63 g, 4.56 mmol) in dry tetrahydrofuran (8 mL) at [0°C.] The mixture was stirred at [45°C] overnight. The mixture was allowed to cool to rt, filtered and evaporated to dryness. Purification of the residue by silica gel column chromatography, eluting with a mixture of ethyl acetate and n-heptane (70: 30), afforded [3-CHLORO-1-MORPHOLIN-4-YL-PROPANE] (156 mg, 42 percent). A solution of 3-chloro-1-morpholin-4-yl-propane (7.6 mg, 0.046 mmol) in [DRY N, N-] [DIMETHYLFORMAMIDE] (0.10 mL) was added to a solution of 118AF99-121 (15 mg, 0.037 mmol) and caesium carbonate (40 mg, 0.123 mmol) in a mixture of dry [N, N-] [DIMETHYLFORMAMIDE] and acetonitrile (1: 2, 0. 30 mL). After addition of sodium iodide (7.0 mg, 0.047 mmol) the mixture was shaken overnight at [60°C.] The mixture was allowed to cool to rt. Acetonitrile was removed by evaporation under reduced pressure and the residue was partitioned between dichloromethane (2 mL) and water (1 mL). The organic layer was evaporated to dryness. Purification of the residue by preparative reversed phase HPLC [(CIS)] afforded the desired compound (6.1 mg, 32 percent). LCMS [M/Z] 527 [[M+H] +.] HPLC tR= 6.2 min.A solution of l-chloro-3-bromopropane in dry tetrahydrofuran (2 mL) was added to a cold suspension of morpholine (200 mg, 2.29 mmol) and sodium carbonate (0.63 g, 4.56 mmol) in dry tetrahydrofuran (8 mL) at 03-Morpholinopropanethiol [0376] To a suspension of l-bromoro-3-chloropropane (30.00 g, 191 mmol) and potassium carbonate (14.00 g, 101 mmol) in dichloromethane (160 ml) was added morpholine (4.00 g, 46 mmol) in portions. Then the mixture was stirred at room temperature overnight. The mixture was filtered and evaporated under reduced pressure. The residue was purified by chromatography (ethyl acetate) to give 5.60 g of product.

Uses

Gefitinib intermediate

Computed Properties

Molecular Weight:163.64
XLogP3:0.8
Hydrogen Bond Acceptor Count:2
Rotatable Bond Count:3
Exact Mass:163.0763918
Monoisotopic Mass:163.0763918
Topological Polar Surface Area:12.5
Heavy Atom Count:10
Complexity:83.7
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of 4-(3-Chloropropyl)morpholine

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.